<DOC>
	<DOCNO>NCT02009761</DOCNO>
	<brief_summary>BI 655064 administer subcutaneously weekly patient immune thrombocytopenic purpura ( ITP ) 12 week .</brief_summary>
	<brief_title>Multiple Rising Does Study ( Subcutaneous Doses ) BI 655064 Male Female Patients With Chronic Primary Immune Thrombocytopenic Purpura ( ITP ) .</brief_title>
	<detailed_description />
	<mesh_term>Purpura , Thrombocytopenic</mesh_term>
	<mesh_term>Purpura</mesh_term>
	<mesh_term>Purpura , Thrombocytopenic , Idiopathic</mesh_term>
	<criteria>Inclusion criterion : Male female chronic immune ITP patient Exclusion criterion : Any treatment ITP exclude except stable dose corticosteroid ( 20 mg )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>